Literature DB >> 15761931

Buccal permeation of buspirone: mechanistic studies on transport pathways.

Raj Birudaraj1, Bret Berner, Steve Shen, Xiaoling Li.   

Abstract

The transport of buspirone across porcine buccal mucosa in vitro was investigated to elucidate the mechanisms of transport and permeation enhancement. The apparent permeability increased with an increase in pH to a lesser degree than the dependence of the partition coefficient. Whereas the lipophilic or apparent transcellular pathway was found to be the dominant buccal transport route for buspirone, ionized species contributed significantly to transport at acidic pH. At neutral pH, bile salts did not increase the flux of the lipophilic species of buspirone, and in contrast to its effect on stratum corneum, aqueous propylene glycol alone did enhance the flux of buspirone across buccal mucosa in vitro. The use of an enhancer combination containing 5% oleic acid, 40% propylene glycol in buffer resulted in the greatest flux, and this was consistent with the effect of this combined enhancer on the flux of lipophilic drugs across stratum corneum and the dominance of the transcellular pathway for buspirone at neutral pH. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761931     DOI: 10.1002/jps.20208

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory.

Authors:  Anthony R Geonnotti; David F Katz
Journal:  Biophys J       Date:  2006-06-30       Impact factor: 4.033

2.  Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.

Authors:  Mutasem M Rawas-Qalaji; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2006-04-28       Impact factor: 3.246

3.  In silico prediction of drug permeability across buccal mucosa.

Authors:  Amit Kokate; Xiaoling Li; Paul J Williams; Parminder Singh; Bhaskara R Jasti
Journal:  Pharm Res       Date:  2009-01-30       Impact factor: 4.200

4.  Early docosahexaenoic and arachidonic acid supplementation in extremely-low-birth-weight infants.

Authors:  Daniel T Robinson; Michael Caplan; Susan E Carlson; Rachel Yoder; Karna Murthy; Brandy Frost
Journal:  Pediatr Res       Date:  2016-06-03       Impact factor: 3.756

5.  Effect of experimental temperature on the permeation of model diffusants across porcine buccal mucosa.

Authors:  Upendra Dilip Kulkarni; Ravichandran Mahalingam; Xiaoling Li; Indiran Pather; Bhaskara Jasti
Journal:  AAPS PharmSciTech       Date:  2011-05-04       Impact factor: 3.246

6.  Bioadhesive Drug Delivery System for Enhancing the Permeability of a BCS Class III Drug via Hot-Melt Extrusion Technology.

Authors:  Nicole S Mendonsa; Priyanka Thipsay; Dong Wuk Kim; Scott T Martin; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2017-02-28       Impact factor: 3.246

7.  Digital Image Disintegration Analysis: a Novel Quality Control Method for Fast Disintegrating Tablets.

Authors:  Osamah Malallah; Zara Rashid; Chee Lok Li; Abdulmalik Alqurshi; Mohamed A Alhanan; Ben Forbes; Paul G Royall
Journal:  AAPS PharmSciTech       Date:  2021-08-16       Impact factor: 3.246

8.  Formulation and Evaluation of New Glimepiride Sublingual Tablets.

Authors:  Wafa Al-Madhagi; Ahmed Abdulbari Albarakani; Abobakr Khaled Alhag; Zakaria Ahmed Saeed; Nahlah Mansour Noman; Khaldon Mohamed
Journal:  J Pharm (Cairo)       Date:  2017-02-05

9.  Hydralazine HCl rapidly disintegrating sublingual tablets: simple dosage form of higher bioavailability and enhanced clinical efficacy for potential rapid control on hypertensive preeclampsia.

Authors:  Samar Genedy; Ahmed Khames; Amal Hussein; Hatem Sarhan
Journal:  Drug Des Devel Ther       Date:  2018-11-05       Impact factor: 4.162

10.  New Insights on the Mechanism of Fatty Acids as Buccal Permeation Enhancers.

Authors:  Cristina Padula; Silvia Pescina; Sara Nicoli; Patrizia Santi
Journal:  Pharmaceutics       Date:  2018-10-24       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.